✦ LIBER ✦

A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy

✍ Scribed by Shibamoto, Y; Ohshio, G; Hosotani, R; Nishimura, Y; Manabe, T; Imamura, M; Abe, M

Book ID: 109837464
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 1013 KB
Volume: 76
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1997.580

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I study of a hypoxic cell sensit

A Phase I study of a hypoxic cell sensitizer KU-2285 in combination with conventional radiotherapy

✍ Yuta Shibamoto; Masaji Takahashi; Mitsuyuki Abe 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 422 KB

In vivo radiosensitizing activity of a n

In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.

✍ Keisuke Sasai; Masato Fushiki; Yutaka Yukawa; Yuta Shibamotlo; Lin Zhou; Sei-ich 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 109 KB

In vivo radiosensitizing activity of a n

In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation

✍ Keisuke Sasai; Masato Fushiki; Yutaka Yukawa; Sumio Suyama; Hiroyuki Iwai; Yuta 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 474 KB

A Phase I/II study of carboplatin combin

A Phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas

✍ Jeffrey Allen; Joao Siffert; Bernadine Donahue; Anita Nirenberg; Regina Jakacki; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## BACKGROUND. Brainstem gliomas often respond to radiotherapy but long term disease control is exceptional. The concomitant administration of a chemotherapy agent with radiosensitizing properties such as carboplatin may increase the efficacy of radiotherapy.

A phase I study of the combination of tw

A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: Toxicity and pharmacokinetics

✍ Hugh F.V. Newman; Norman M. Bleehen; Paul Workman 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 535 KB

Paclitaxel in combination with cisplatin

Paclitaxel in combination with cisplatin, etoposide and thoracic radiotherapy for limited small cell lung cancer. A Phase II study

✍ R.M. Bremnes; S. Sundstrøm; J. Vilsvik; U. Aasebø 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 229 KB